Active substanceAscorbic acidAscorbic acid
Similar drugsTo uncover
  • Asvitol®
    pills inwards 
  • Ascovit®
    pills inwards 
    VALEANT, LLC     Russia
  • Ascovit®
    powder inwards 
    VALEANT, LLC     Russia
  • Ascovit®
    pills inwards 
    Natur Product Europe BV     Netherlands
  • Ascorbic acid
    pills inwards 
    ALTAYVITAMINS, CJSC     Russia
  • Ascorbic acid
    solution w / m in / in 
  • Ascorbic acid
    solution w / m in / in 
  • Ascorbic acid
    pills inwards 
    VEROPHARM SA     Russia
  • Ascorbic acid
    solution w / m in / in 
    ATOLL, LLC     Russia
  • Ascorbic acid
    powder inwards 
  • Ascorbic acid
    powder inwards 
    MARBIOFARM, OJSC     Russia
  • Ascorbic acid
    powder inwards 
    MEDISORB, CJSC     Russia
  • Ascorbic acid
    powder inwards 
    OZONE, LLC     Russia
  • Ascorbic acid
    pills inwards 
    BIOSINTEZ, PAO     Russia
  • Ascorbic acid
    solution w / m in / in 
    BIOSINTEZ, PAO     Russia
  • Ascorbic acid
    solution w / m in / in 
  • Ascorbic acid
    solution w / m in / in 
  • Ascorbic acid
    powder inwards 
    LYUMI, LLC     Russia
  • Ascorbic acid
    pills inwards 
  • Ascorbic acid
    pills inwards 
    MARBIOFARM, OJSC     Russia
  • Ascorbic acid
    solution w / m in / in 
    DALHIMFARM, OJSC     Russia
  • Ascorbic acid
    solution w / m in / in 
  • Ascorbic acid
    solution w / m in / in 
    ESKOM NPK, OAO     Russia
  • Ascorbic acid
    solution w / m in / in 
  • Ascorbic acid
    pills inwards 
    MEDISORB, CJSC     Russia
  • Ascorbic acid
    solution w / m in / in 
    BIOCHEMIST, OJSC     Russia
  • Ascorbic acid
    pills inwards 
    VALENTA PHARM, PAO     Russia
  • Ascorbic acid
    solution w / m in / in 
  • Ascorbic acid
    powder inwards 
    ROSFARM, CJSC     Russia
  • Ascorbic acid
    pills inwards 
    DALHIMFARM, OJSC     Russia
  • Ascorbic acid
    powder inwards 
    MELIGEN FP, CJSC     Russia
  • Ascorbic acid
    powder inwards 
  • Ascorbic acid bufus
    solution w / m in / in 
    UPDATE OF PFC, CJSC     Russia
  • Ascorbic acid-Vial
    solution w / m in / in 
    VIAL, LLC     Russia
  • Ascorbic acid-SOLOfarm
    solution w / m in / in 
    GROTEKS, LLC     Russia
  • Ascorbic acid-UBF
    pills inwards 
    URALBIOFARM, OJSC     Russia
  • ALTAYVITAMINS, CJSC     Russia
  • Vaginorm-C®
    pills the vagina. 
    Polikhem S.A.     Luxembourg
  • Vitamin C
    pills inwards 
    Soko Stark DOO.     Serbia
  • Rostvert
    pills inwards 
  • Setwork 500
    capsules inwards 
  • Cevicap®
    drops inwards 
  • Celascon® Vitamin C
    pills inwards 
    Zentiva as.     Czech Republic
  • Celascon® effect Vitamin C
    capsules inwards 
    Zentiva c.s.     Czech Republic
  • Dosage form: & nbspchewing tablets
    Composition:

    Tablets, chewing

    composition: 1 tablet contains:

    acid ascorbic (vitamin C) - 25 mg;

    Excipients: sucrose, glucose, calcium stearate, potato starch, aromatic food citrus or fruit essence.

    Chewable lemon tablets

    composition: 1 tablet contains:

    acid ascorbic (vitamin C) - 25 mg;

    Excipients: sucrose, glucose, calcium stearate, potato starch, anhydrous citric acid, lemon flavoring, coloring quinoline yellow E 104;

    Tablets, chewing strawberry

    composition: 1 tablet contains:

    acid ascorbic (vitamin C) - 25 mg;

    Excipients: sucrose, glucose, calcium stearate, potato starch, anhydrous citric acid, strawberry flavor, dye Ponceau 4R E 124;

    Masticated chewing tablets

    composition: 1 tablet contains:

    acid ascorbic (vitamin C) - 25 mg;

    Excipients: sucrose, glucose, calcium stearate, potato starch, flavoring crumpled, dye quinoline yellow E 104, E 132 colorant indigo carmine

    Description:

    Tablets 25 mg: tablets white or almost white, flat-cylindrical with a bevel.

    Lemon tablets 25 mg: Tablets of light yellow color are flat-faced with a facet, admissions of a yellow color are allowed.

    Strawberry tablets 25 mg: tablets of light pink color are flat-faced with a bevel, blotches of pink color are allowed.

    Mint tablets 25 mg: tablets of light green color are flat-faced with a facet, green inclusions are allowed.

    Pharmacotherapeutic group:Vitamin
    ATX: & nbsp

    A.11.G.A.01   Ascorbic acid

    Pharmacodynamics:

    Ascorbic acid actively participates in oxidation-reduction reactions, has a nonspecific general stimulating and antioxidant effect on the body. Increases the adaptive abilities of the body and its resistance to infections; promotes regeneration processes.

    Indications:

    Prevention and treatment of hypo- and vitamin deficiency vitamin C.

    As an auxiliary: hemorrhagic diathesis, nasal, uterine, pulmonary and other hemorrhages, radiation sickness; an overdose of anticoagulants, infectious diseases and intoxications, liver disease, nephropathy of pregnant women, Addison's disease, sluggishly healing wounds and bone fractures, dystrophy and other pathological processes. The drug is prescribed for increased physical and mental stress, during pregnancy and breastfeeding, intensive growth, with stress, during recovery after long and severe illness.

    Contraindications:

    Hypersensitivity to the components of the drug, thrombophlebitis, a tendency to thrombosis, diabetes mellitus.

    Carefully:

    Hyperoxalaturia, renal failure, hemochromatosis, thalassemia, polycythemia, leukemia, sideroblastic anemia, glucose-6-phosphate dehydrogenase deficiency, sickle-cell anemia, progressive malignant diseases, pregnancy.

    Pregnancy and lactation:

    The minimum daily requirement for ascorbic acid in II-III trimesters of pregnancy - about 60 mg.

    The minimum daily requirement for breastfeeding is 80 mg. A mother's diet containing an active amount of ascorbic acid is sufficient to prevent vitamin C deficiency in an infant (it is recommended not to exceed the maximum monthly requirement for ascorbic acid in a nursing mother).

    Dosing and Administration:

    The drug is taken orally after a meal. Before consumption, chew.

    For prophylaxis: for adults, 0,05-0,1 g (2-4 tablets) per day; children over 5 years of 0.05 g (2 tablets) per day.

    For treatment: adults 0.05-0.1 g (2-4 tablets) 3-5 times a day; children over 5 years of 0.05-0.1 g (2-4 tablets) 2-3 times a day.

    During pregnancy and breastfeeding, 0.3 g per day for 10-15 days, then 0.1 g (4 tablets) per day.

    The duration of the course of treatment with the drug is determined by the doctor.

    Side effects:

    From the central nervous system (CNS): headache, fatigue, with prolonged use of large doses - increased excitability of the central nervous system, sleep disturbance.

    From the digestive system: irritation of the gastrointestinal mucosa, nausea, vomiting, diarrhea, stomach cramps.

    From the endocrine system: oppression of the insular pancreas function (hyperglycemia, glucosuria).

    From the urinary system: when used in high doses - hyperoxalaturia and the formation of urinary stones from calcium oxalate.

    From the side of the cardiovascular system: thrombosis, when used in high doses - increased blood pressure, development of microangiopathies, myocardial dystrophy.

    Allergic reactions: skin rash, rarely - anaphylactic shock.

    Laboratory indicators: thrombocytosis, hyperprothrombinemia: erythropenia, neutrophilic leukocytosis, hypokalemia.

    Other: hypervitaminosis, a feeling of heat, with prolonged use of large doses - sodium retention (Na+) and fluid, a disruption of zinc metabolism (Zn2+), copper (Cu2+).

    Overdose:

    When taking more than 1 g per day, heartburn, diarrhea, difficulty urinating and / or staining the urine red, hemolysis (in patients with deficiency of glucose-6-phosphate dehydrogenase) are possible.

    If any side effects occur, stop taking the medication and consult a doctor.

    Interaction:

    Increases the concentration in the blood of antibiotics of the penicillin group and tetracyclines; in a dose of 1 g / day. increases the bioavailability of ethinyl estradiol.

    Improves absorption in the intestines of iron preparations (converts trivalent iron into bivalent); can increase the excretion of iron with simultaneous application with deferoxamine.

    Acetylsalicylic acid (ASA), oral contraceptives, fresh juices and alkaline drink reduce absorption and absorption.

    When used simultaneously with ASA, ascorbic acid is excreted in the urine and ASA excretion decreases. ASA reduces the absorption of ascorbic acid by about 30%.

    Increases the risk of developing crystalluria when combined with salicylates and sulfonamidesshort-acting, slows the excretion of kidney acids, increases the excretion of drugs that have an alkaline reaction (including alkaloids), reduces the concentration of oral contraceptives in the blood.

    Increases the overall clearance of ethanol, which in turn reduces the concentration of ascorbic acid in the body.

    Preparations of quinoline series (fluoroquinolones, etc.), calcium chloride, salicylates, glucocorticosteroids with prolonged use deplete the supply of ascorbic acid.

    With simultaneous use reduces the chronotropic effect of isoprenaline.

    With prolonged use or use in high doses, it can disrupt the interaction of disulfiram-ethanol.

    In high doses increases the renal excretion of mexiletine.

    Barbiturates and primidon increase the excretion of ascorbic acid in the urine.

    Reduces the therapeutic effect of antipsychotic agents (phenothiazine derivatives), tubular reabsorption of amphetamine and tricyclic antidepressants.

    Special instructions:

    In connection with the stimulating effect of ascorbic acid on the formation of corticosteroid hormones, it is necessary to monitor the indices of arterial pressure.

    With prolonged use of large doses, oppression of the insulin function of the pancreas is possible, so during treatment it must be regularly monitored.

    In patients with elevated iron levels in the body, ascorbic acid should be used in minimal doses.

    Assigning ascorbic acid to patients with rapidly proliferating and intensely metastatic tumors can aggravate the course of the process. Ascorbic acid, as a reducing agent, can distort the results of various laboratory tests (blood glucose, bilirubin, transaminase activity.

    Form release / dosage:Tablets are chewable.
    Packaging:

    10 tablets are wrapped in a label-label of a Polyphan film or from a base paper for waxing. 10 pack labels are wrapped in paper (intermediate packing) from a parchment or wrapping paper.

    For 40 intermediate packages, together with instructions for use in the quantity corresponding to the number of label packages, are put in a box.
    Storage conditions:

    Store in a dry, dark place at a temperature of no higher than 25 ° C.

    Keep out of the reach of children.

    Shelf life:

    1 year.

    The drug should be used before the date indicated on the package.

    Terms of leave from pharmacies:Without recipe
    Registration number:П N011921 / 01
    Date of registration:03.04.2008 / 11.04.2012
    Expiration Date:Unlimited
    The owner of the registration certificate:KIEVSKY VITAMIN FACTORY, PAOKIEVSKY VITAMIN FACTORY, PAO Ukraine
    Manufacturer: & nbsp
    Representation: & nbspArt Bureau Ltd.Art Bureau Ltd.Russia
    Information update date: & nbsp11.01.2018
    Illustrated instructions
      Instructions
      Up